/PRNewswire/ Pinnacle Clinical Research ("Pinnacle"), a portfolio company of LongueVue Capital ("LVC") and a leading site organization specializing in.
/PRNewswire/ November 16, 2022 – LongueVue Capital ("LVC") is pleased to announce it has partnered with Pinnacle Clinical Research, LLC ("Pinnacle" or the.
Pinnacle Clinical Research operates clinical trial sites across Texas with a focus on hepatology and non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
LongueVue Capital Onboards Dedicated Life Sciences Operating Partner, Adrian Otte, And Completes Investment In KPS Life, LLC
News provided by
Share this article
Share this article
NEW ORLEANS, Jan. 12, 2021 /PRNewswire/ LongueVue Capital ( LVC ), together with its Life Sciences Operating Partner, Adrian Otte, is pleased to announce it has partnered with CEO David Kelly and the management team of KPS Life, LLC ( KPS or the Company ) to recapitalize the business and provide growth capital. The structured debt and preferred equity investment represents the first institutional capital for KPS, a functional service provider ( FSP ) that offers outsourced clinical trial services to pharmaceutical companies worldwide.